» Articles » PMID: 16636355

Use of Etomidate As an Induction Agent for Rapid Sequence Intubation in a Pediatric Emergency Department

Overview
Journal Acad Emerg Med
Publisher Wiley
Specialty Emergency Medicine
Date 2006 Apr 26
PMID 16636355
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Although etomidate is widely used for rapid sequence intubation (RSI), there is no consensus on the optimal induction agent and no prospective pediatric emergency department (ED) study exists. The objective of this study was to assess the effectiveness and safety of etomidate as an induction agent for RSI in the pediatric ED.

Methods: Data on RSI conditions and complications were collected prospectively on patients undergoing RSI in a tertiary pediatric ED from January 2003 to December 2003. ED hemodynamic data and inpatient data were collected retrospectively via chart review.

Results: Seventy-seven of 101 patients requiring intubation underwent RSI with etomidate. The mean (+/- SD) age was 8.2 (+/- 6.2) years. All 77 patients were successfully intubated. Intubation condition data were available for 69 of 77 patients (89.6%). Conditions were good in 68 of 69 (99%; 95% confidence interval = 92.2% to 99.9%). The mean (+/- SD) maximal percent decrease in systolic blood pressure was 10% (+/- 13.6%). A greater than 20% maximal percent decrease in systolic blood pressure occurred in 12 of 69 patients (17.4%; 95% confidence interval = 9.3% to 28.4%). There was no relationship between seizures after etomidate administration and prior seizure history (p = 0.25). Corticosteroids were given to 29 of 77 patients post-RSI for varying diagnoses. All eight patients given corticosteroids for shock were in shock at the time of intubation.

Conclusions: In the pediatric ED setting, etomidate as an induction agent provided successful RSI conditions and resulted in varied hemodynamic changes that were especially favorable in those patients presenting in decompensated shock. Hypotension and seizures were uncommon and occurred in patients with confounding diagnoses. Until the significance of a single dose of etomidate on adrenal dysfunction is further clarified, caution should be used in those patients at risk for adrenal insufficiency.

Citing Articles

Use of Etomidate for Rapid Sequence Intubation (RSI) in Pediatric Trauma Patients: An Exploratory National Survey.

Cies J, Moront M, Moore Ii W, Ostrowicki R, Gannon K, Da-Silva S Pharmacy (Basel). 2017; 3(4):197-209.

PMID: 28975913 PMC: 5597104. DOI: 10.3390/pharmacy3040197.


Continuous-Infusion Etomidate in a Patient Receiving Extracorporeal Membrane Oxygenation.

LaRochelle J, Desselle B, Rossi J J Pediatr Pharmacol Ther. 2017; 22(1):65-68.

PMID: 28337083 PMC: 5341534. DOI: 10.5863/1551-6776-22.1.65.


Etomidate in pediatric anesthesiology: Where are we now?.

Tobias J Saudi J Anaesth. 2015; 9(4):451-6.

PMID: 26543467 PMC: 4610094. DOI: 10.4103/1658-354X.159475.


Clinical study of etomidate emulsion combined with remifentanil in general anesthesia.

Weng D, Huang M, Jiang R, Zhan R, Yang C Drug Des Devel Ther. 2013; 7:771-6.

PMID: 23990706 PMC: 3753064. DOI: 10.2147/DDDT.S45979.


Pro-con debate: etomidate or ketamine for rapid sequence intubation in pediatric patients.

Scherzer D, Leder M, Tobias J J Pediatr Pharmacol Ther. 2012; 17(2):142-9.

PMID: 23118665 PMC: 3470433. DOI: 10.5863/1551-6776-17.2.142.